pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-605 |
Genomic Coordinates | chr10: 51299573 - 51299655 |
Synonyms | MIRN605, hsa-mir-605, MIR605 |
Description | Homo sapiens miR-605 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-605-3p | ||||||||||||||||||||||||||||
Sequence | 51| AGAAGGCACUAUGAGAUUUAGA |72 | ||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CEP104 | ||||||||||||||||||||
Synonyms | CFAP256, GlyBP, JBTS25, KIAA0562, ROC22 | ||||||||||||||||||||
Description | centrosomal protein 104 | ||||||||||||||||||||
Transcript | NM_014704 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CEP104 | |||||||||||||||||||||
3'UTR of CEP104 (miRNA target sites are highlighted) |
>CEP104|NM_014704|3'UTR 1 CGCGGCGCTCGGGCTCCTTGGTCTCTGTGAGGGATGGAGCGGGTCTCCTGATTCTACACCATCTCTCCAGAACTCTCTGG 81 CCTTGGTGGCCCCATGCTCTGGCTGCTGTCCCCAGCTCCCCGCCGTGCACGCCTCTTACGCGTCTGTGCCGTCAGCTCTC 161 GTGCAAACGATATGGATGCAGCTAACCAAAGATCCTGCGTGCAGTGCCAGGACCTGGCCGCACTGTACATTAAGCCTTCA 241 GGGCTGTCTCAGGCCTTCCTTAGAATCAGAGAAGGAAGCGTCCTGTTTGGAGAGAGCCAGAGAGCACCGCCGGGAGGCGC 321 TCGCGCAAGGCCACGGTCAGCACAGGCACGGTCCCGCTTTCCTTAGTGCTTGGAGCAATTTCCATAAAACATTCACCAGA 401 AACCTTTTGCACATCGGTCTCTGCCACACGCAGTAGAATTTCCGCAGGGCTGTGGCTCGGCCAGCAGCGGTTCCAGGAGA 481 GTGGCGGTGCGCACGGGCCTCCAGCCGTGCCTTCCCCCTGCAGGCCCCGTCTGCTGGGCCTGCTGCCCAGTGCACTCAGC 561 CCCAGGTAGCAGAACTCACGTTCCCACTATAGCAAGAAATAAAGGCAAAAGAGAACATCTTTTTTTTAATCGTAGTTTTT 641 TTGAGAATTGGTCCCACCTCAGCCGCACCTTGCTGGATGCTTCTCCAGTAGTGCTGCCCCTGTGACAGGCATCAGCTCCC 721 TGCTGGAACTGAGGTAGACACAGGTGTGGGCCCTTCCCGTGCCTTTGCTCAGAGGCGCTTCACTTTCTCCACACTTTCGA 801 ATTCCTAAAGACATGTGGAGGAAGTCACTGTTAAATGAATTTCCACCTGATCACCCTGTGTTCACAGCAGGCAGAAGCCC 881 ACTGGTATGGGCCTCCCGCCCCTTCCACATCCATGTTGTGATTGGATCCATAAGTTTACTTTCTTCAAAGAGTTGATAGG 961 ATGTTTAAAACATCAACACATTGCTTAAAATGATGAAACCAACCCTCAAAAAACAGTCTCCTAACCAGCCATCCCCTCCT 1041 GTGGGAGTGAGCTGGGGGTTTTGTCCATAGCTTTGGTTGGGCCTGTGTCACATCCAGGCAGCCATGTGGAGGGAGTCAGG 1121 GTCTGTCTGGAAGCATCCACCCTCTCGCTGCCCCAGCCTGTGCTCCCAGGGGCCTAGGCTACCATGGACTGAAGGGCAGT 1201 CCCCTCCCACCTGGTGCCCAGGGCTTCTGCTTGCCTCGCTGATGTTGCATGGGCAGACTTCAAAAAGGATAGTTAGAAAG 1281 GTTTGGGTTGATGGAGTTTGCATTAATGCAATTAGTGTATAAATATGTTTTAATTGCCAACCGTGTGAAACAACAAAATA 1361 TCTAAAAACTAATCCCGATTTGAACAATGTACTCCCTGGCCTGGATACATTAATAACCATAAATTTGCATGAATTAATCT 1441 CCACGTTTGGTAAACTAATACCTCTGGTTGACTGAGAATACTGAGTAAGATATAAGACCTACCAGGAACCTTTAAGAATA 1521 TGCTCTGCTCAGTGTTGTTTGTCTGCTTGTTTGCGACGGAGTCTCACTGTGTCGCCCGGGCTGCAGTGCAATGGCGTGAT 1601 CTTGGCTCACAGTAACCTCCACCTCCTGGGTTCAAGCAATTCTCCTGCCTCAGCCTCCCTAGTAGCTGGGATTACAGGTG 1681 CACACCACCATGCTCGGCTAATTTTTTCTATTTTTAGTAGAGATGGGGTTTCACCATGTTGGCCAGGCTGGTCTCGAACT 1761 CGTGACCTCATAATCTGCCCACCTTGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACCACGCCCAGGTTAAATGT 1841 GTTTATAAGGAGAGAGGAGGCCAGGCGCGGTGGCTCACGCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGCGGACCA 1921 CCTGAGGTCAGGAGTTCGAGACCAGCCTGGCCAACATGGTGAAACCCCATCTCTACTAAAAATACAAAAATGAGCCAGGC 2001 GTGGTGGCCTGTAGTCCCAGCTACTTGAGAGGCTGAGGCAGGAAAATTGCTTGAACCCGGGAGGTGGAGGTTGCATTGAG 2081 CCCACATCATGCCATTGCACTCCAGCCCAGGCGACAGAGCGAGACTCCGTCTCGAAAAAAAAAAAAAGTATAAGGAGAGA 2161 AATAACTTTAAAGTTTATTAGACAAAACAGAGTATAGATGCCAAGATGTCTGTAAAATGATTTTTTCTGGTTTTAAAGAG 2241 ATGTTGGCCATTATTTTCTAATCCATTTTTAAAATACAGACAAAACACTTCTTTAAACAGAACAAGAATGAGAAAAGTTA 2321 ACCAAGGAATTATTCTTTTCTCACCAATCAACACTTTTAAGAAATATATATATATATATACACACATATACACATGCCTT 2401 CTATATATTGTAACTTAAAGAAAATACTTATAAAAAGACTTCATTTTTAGTGATTGACAAGCAAACGGGTTCATTTAAAA 2481 CAGGTTCCTCTTTTGTTAGTTACAGGGGGTTTTTTTGTTGTTTTTTTGTTTTTGTTTTTGTTTTGCGGGGGTGGTGGGGT 2561 TTGAGACGGAGTCTTGCTCTGTTGCCTAGGCTGGAGTGCAGTGGCGCGATCTTGGCCCCCTGCAACCTCCGCCTCCCGGG 2641 TTCGAGCAATTCTCCTGCCTCAGCCTCCCGAGTAGCTGGGATTACAGGCGTGTGTCACCACGCCTGGCTAATTTTTTTGT 2721 ATTTTTAGTAGAGACGGGGTTTCACCATATTGGCCAGGCTGGTCTCAAACTCCTGACCTTGTGATCCACCCACCTCGGCC 2801 TCCCAAAGTGCTGGAATTACAGGCATGAGCCACCGCGCCCGGCCCAATCATGTGTTTTTGTTGAAATGATCCTACCAGTG 2881 ATTAGTGGCTATTGAGAGTTTTACAGGGTTATACATTGTTAAGGGACCAAGAATCAAGTACAAAAAATTAAAAAGGAACT 2961 GTAAAATCCCTTGGTCATTCATAAATAAATATCTAAATTAGGAATACTAATTAATTGAATTTTCACTCATGAGTATGTTC 3041 TGAATATTTAATATTTATTTCTATTATTTTCATATGTTAAGATATTCCATTAAATCTAACTTAAAAGAATTGTATGTATA 3121 AATTGGCATTAGGATACAAATGTAAATGTTTTTAATGAAATTTTGCAACTTTTTAATATTTTAACATAGTTTTCTATTTG 3201 TCTTTATTTCAAGTACCAGAATTACAAAATATCTAAGTAATATATTTTTGTTGTCGTTTTAGGGCTTAAGGGTTAATTCA 3281 CCCAGAGTATATTAATATAATAAAAAGATCACTAAATGTTT Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 9731.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 9731.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065667. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000378230.3 | 3UTR | AUAUAUAUAUAUAUAUACACACAUAUACACAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1065667 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_6 |
Location of target site | ENST00000378230.3 | 3UTR | AAUAUAUAUAUAUAUAUACACACAUAUACACAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
100 hsa-miR-605-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT061339 | WEE1 | WEE1 G2 checkpoint kinase | ![]() |
![]() |
2 | 4 | ||||||
MIRT061584 | BTG2 | BTG anti-proliferation factor 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT076140 | WDR81 | WD repeat domain 81 | ![]() |
![]() |
2 | 2 | ||||||
MIRT079361 | CCDC137 | coiled-coil domain containing 137 | ![]() |
![]() |
2 | 2 | ||||||
MIRT079547 | VAMP3 | vesicle associated membrane protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT096242 | CANX | calnexin | ![]() |
![]() |
2 | 2 | ||||||
MIRT243877 | G3BP1 | G3BP stress granule assembly factor 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT249186 | AKIRIN1 | akirin 1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT273604 | SP1 | Sp1 transcription factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT316766 | FOXC1 | forkhead box C1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT322410 | PPP2R2A | protein phosphatase 2 regulatory subunit Balpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT370117 | TRIB3 | tribbles pseudokinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT392725 | UBN2 | ubinuclein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT406910 | PTBP1 | polypyrimidine tract binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT407440 | CTDSP1 | CTD small phosphatase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT441887 | RD3 | retinal degeneration 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT444979 | C15orf52 | chromosome 15 open reading frame 52 | ![]() |
![]() |
2 | 2 | ||||||
MIRT445241 | FOXD4 | forkhead box D4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT445500 | FOXD4L5 | forkhead box D4 like 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT445503 | FOXD4L4 | forkhead box D4 like 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447025 | FOXD4L1 | forkhead box D4 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447743 | TMCC3 | transmembrane and coiled-coil domain family 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT448761 | HDX | highly divergent homeobox | ![]() |
![]() |
2 | 2 | ||||||
MIRT450003 | HAX1 | HCLS1 associated protein X-1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452830 | FAM131B | family with sequence similarity 131 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT452872 | LAX1 | lymphocyte transmembrane adaptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453506 | ARRB1 | arrestin beta 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454169 | HIST1H2BK | histone cluster 1 H2B family member k | ![]() |
![]() |
2 | 2 | ||||||
MIRT458742 | CES2 | carboxylesterase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT459166 | HSPA6 | heat shock protein family A (Hsp70) member 6 | ![]() |
![]() |
2 | 21 | ||||||
MIRT460246 | IL17RB | interleukin 17 receptor B | ![]() |
![]() |
2 | 4 | ||||||
MIRT460514 | SDE2 | SDE2 telomere maintenance homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT460698 | RNF157 | ring finger protein 157 | ![]() |
![]() |
2 | 2 | ||||||
MIRT461481 | METTL1 | methyltransferase like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT462617 | C20orf27 | chromosome 20 open reading frame 27 | ![]() |
![]() |
2 | 4 | ||||||
MIRT463233 | ZNF131 | zinc finger protein 131 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465699 | TNPO2 | transportin 2 | ![]() |
![]() |
2 | 8 | ||||||
MIRT466304 | TIMM22 | translocase of inner mitochondrial membrane 22 | ![]() |
![]() |
2 | 2 | ||||||
MIRT468957 | RPS14 | ribosomal protein S14 | ![]() |
![]() |
2 | 6 | ||||||
MIRT469571 | RARA | retinoic acid receptor alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT469685 | RAB5B | RAB5B, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT470800 | PMP22 | peripheral myelin protein 22 | ![]() |
![]() |
2 | 2 | ||||||
MIRT471649 | PANK2 | pantothenate kinase 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT471722 | OTUB1 | OTU deubiquitinase, ubiquitin aldehyde binding 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472281 | NFIB | nuclear factor I B | ![]() |
![]() |
2 | 4 | ||||||
MIRT473680 | MAPKBP1 | mitogen-activated protein kinase binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475859 | H6PD | hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase | ![]() |
![]() |
2 | 2 | ||||||
MIRT477326 | EPHA2 | EPH receptor A2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT477831 | DYRK3 | dual specificity tyrosine phosphorylation regulated kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT478572 | CTNND1 | catenin delta 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT479634 | CD81 | CD81 molecule | ![]() |
![]() |
2 | 2 | ||||||
MIRT481950 | ANKRD11 | ankyrin repeat domain 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT483696 | ZNF74 | zinc finger protein 74 | ![]() |
![]() |
2 | 6 | ||||||
MIRT488798 | MALT1 | MALT1 paracaspase | ![]() |
![]() |
2 | 2 | ||||||
MIRT489066 | STARD3 | StAR related lipid transfer domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492533 | PSMD11 | proteasome 26S subunit, non-ATPase 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492857 | NRARP | NOTCH regulated ankyrin repeat protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT496793 | BTRC | beta-transducin repeat containing E3 ubiquitin protein ligase | ![]() |
![]() |
2 | 2 | ||||||
MIRT500122 | ZNF106 | zinc finger protein 106 | ![]() |
![]() |
2 | 4 | ||||||
MIRT505359 | TMEM167A | transmembrane protein 167A | ![]() |
![]() |
2 | 2 | ||||||
MIRT506786 | KLHL15 | kelch like family member 15 | ![]() |
![]() |
2 | 6 | ||||||
MIRT510692 | SRM | spermidine synthase | ![]() |
![]() |
2 | 6 | ||||||
MIRT515841 | CEP104 | centrosomal protein 104 | ![]() |
![]() |
2 | 4 | ||||||
MIRT516448 | ADAMTS4 | ADAM metallopeptidase with thrombospondin type 1 motif 4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT528855 | PKP1 | plakophilin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT533848 | TET3 | tet methylcytosine dioxygenase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT539025 | ATXN7L1 | ataxin 7 like 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT542872 | NR6A1 | nuclear receptor subfamily 6 group A member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT546543 | SATB2 | SATB homeobox 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT554114 | SMARCE1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT560569 | ZNF460 | zinc finger protein 460 | ![]() |
![]() |
2 | 2 | ||||||
MIRT560796 | EPM2AIP1 | EPM2A interacting protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT562836 | GCFC2 | GC-rich sequence DNA-binding factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT563109 | IFRD2 | interferon related developmental regulator 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT564177 | MRPL49 | mitochondrial ribosomal protein L49 | ![]() |
![]() |
2 | 2 | ||||||
MIRT564283 | ASB1 | ankyrin repeat and SOCS box containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT564350 | USP22 | ubiquitin specific peptidase 22 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565279 | TNFRSF21 | TNF receptor superfamily member 21 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565338 | TMEM104 | transmembrane protein 104 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565905 | SCAMP2 | secretory carrier membrane protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT567108 | ITGB1 | integrin subunit beta 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT567601 | FANCF | Fanconi anemia complementation group F | ![]() |
![]() |
2 | 2 | ||||||
MIRT567779 | DGAT2 | diacylglycerol O-acyltransferase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT568075 | CENPQ | centromere protein Q | ![]() |
![]() |
2 | 2 | ||||||
MIRT624304 | COL12A1 | collagen type XII alpha 1 chain | ![]() |
![]() |
2 | 2 | ||||||
MIRT644395 | CDKL1 | cyclin dependent kinase like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT661547 | ZNF674 | zinc finger protein 674 | ![]() |
![]() |
2 | 4 | ||||||
MIRT670949 | IRAK3 | interleukin 1 receptor associated kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT672951 | AKAP5 | A-kinase anchoring protein 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT697426 | ZFP36 | ZFP36 ring finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT700793 | PIAS2 | protein inhibitor of activated STAT 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT702657 | ITGA3 | integrin subunit alpha 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708945 | FZR1 | fizzy and cell division cycle 20 related 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713657 | PLCE1 | phospholipase C epsilon 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT719239 | CYSLTR2 | cysteinyl leukotriene receptor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT719951 | BLOC1S6 | biogenesis of lysosomal organelles complex 1 subunit 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT722048 | HLA-E | major histocompatibility complex, class I, E | ![]() |
![]() |
2 | 2 | ||||||
MIRT722201 | URM1 | ubiquitin related modifier 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT724790 | C1D | C1D nuclear receptor corepressor | ![]() |
![]() |
2 | 2 | ||||||
MIRT734347 | CYP2B6 | cytochrome P450 family 2 subfamily B member 6 | ![]() |
![]() |
![]() |
3 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|